Furthermore, other studies have demonstrated that blocking the secretion or exercise of soluble S100A8/A9 advanced could possibly be a promising therapeutic solution in surviving patients, who experienced decrease levels of S100A8/A9, in comparison to non-survivors. The blocking has the probable to circumvent liver injury and bacterial disseminatio